SHL Medical, a leader and front-runner in advanced technologies for autoinjectors and specialty drug delivery systems, announced the launch of a new webpage for its Molly® Connected Cap, a smart, retrofittable add-on for the market-proven Molly modular platform autoinjector.
In the rapidly evolving landscape of healthcare, the influence of digital health is creating an irreversible shift in home-based treatments. The Molly Connected Cap demonstrates SHL Medical’s commitment to developing innovative solutions that meet these evolving trends while ensuring that new technologies can be realized in the real-world setting. As an agile solution for adding or retrofitting connectivity to new or existing autoinjectors, the Molly Connected Cap enables the collection of real-world data to support remote adherence monitoring and other crucial digital health initiatives for patients and payors alike.
The new webpage makes it easier for visitors to navigate the Molly® Connected Cap’s features while also gaining an in-depth understanding of the added value it brings to the wider healthcare system, including remote adherence monitoring, personalised patient programmes, decentralised clinical trials and value-based reimbursement strategies.
“It’s no secret that the drug delivery industry, along with the digital health landscape, is on the cusp of realising the full potential of connected therapeutics,” said Max Jaeger, Global Head of Marketing at SHL Medical. “As innovation accelerates, we anticipate a future where more collaborative efforts among the drug, device and other crucial stakeholders in healthcare value chain converge to bring about solutions that lead to improved patient adherence and better treatment outcomes.”
The Molly Connected Cap will be featured at the upcoming PODD®, PDA Universe and CPHI Barcelona conferences in October. Drop us a message at digital@shl-medical.com and book a meeting with our digital health experts!